The Ramanbhai Foundation 6th International Symposium on "Advances in New Drug Discovery Technologies And Translational Research"

RBF Symposium Organizing Committee
Last Modified: January 17, 2013

Share article


Dates: February 4-6, 2013
Location: Zydus Research Center, Ahmedabad

Sponsoring Group: RBF Symposium Organizing Committee

Web Page URL: www.rbfsymposium.net

Topics Covered: Focus on Cancer, Pain, Inflammation, Cardio-metabolic, Infectious diseases.

Objectives: Key Features:

  1. A focused audience of high-level scientists and key decision makers.
  2. Unrivaled networking opportunities to meet numerous U.S., European Asian academic institutes, biotech and pharmaceutical companies.
  3. Case studies on drug discovery and development.
  4. New drugs on the horizon.
  5. Developing rational strategies for combination therapy. 6.Translating basic discoveries to Medicines.

Who Should Attend: Industry, Academia

Agenda: Dear Colleagues It's our pleasure to welcome you to participate in the Ramanbhai Foundation 6th International Symposium on "Advances in New Drug Discovery Technologies And Translational Research" to be held in Ahmedabad, India from February 4-6, 2013, with a focus on cancer, pain, inflammation, cardio-metabolic and infectious diseases. The RBF Conference brings together biotechnology and pharmaceutical both from Industry and Academia from India, North America, Europe and the Asia-Pacific region. RBF Symposium has been recognized as a leading scientific and networking conference in Asia over the past many years with participants representing leading companies and academic institutes from around the world. Key Speakers include: - Dr. Peter Schultz, Director, Calibr Institute Professor of Chemistry, The Scripps Research Institute, USA - Dr. Steven G. Reed, Founder, President, Chief Scientific Officer, Infectious Disease Research Institute, USA - Dr. Ajoy Basak, Scientist, Chronic Disease, Ottawa Hospital Research Institute and Principle Investigator, Regional Protein Chemistry Centre, Canada - Dr. Alex Haahr Gouliaev, CEO, Nuevolution, Denmark - Dr. Anil Bhansali, Professor and Head, Department of Endocrinology, PGIMER, Chandigarh, India - Dr. Kapil Dhingra, KAPital Consulting, LLC, USA - Dr. Johanna Holldack, MD, Chief Executive Officer, Telormedix SA, Switzerland. - Dr. Lee Helman, Head Senior Investigator, Molecular Oncology Section, National Cancer Institute, USA - Dr. Purvish M. Parikh, Prof Head. Dept of Medical Oncology, Tata Memorial Hospital, India - Dr. Ranjan Mukherjee, Sr Principal Scientist, Cardiovascular Diseases Research, Bristol-Myers Squibb, USA - Dr. Samit Hirawat, Vice President, Oncology, Novartis, USA - Dr. Jan ter Meulen, Executive Director Vaccine Research, Merck Research Laboratories, USA - Dr. Stephen Yoder, CEO, Pieris AG, Germany more.

Registration Information: To register ONLINE for this conference, please visit, http://www.rbfsymposium.net/registration.asp EARLY REGISTRATION closes on December 31, 2012

Fees: USD 150-300

Continuing Education: No


News
BCS: New Research Highlights Breast Cancer Advances

Sep 22, 2014 - New research advances promise to improve the treatment and management of breast cancer, according to five studies highlighted at the 2009 Breast Cancer Symposium, held from Oct. 8 to 10 in San Francisco.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More